FA
LMAT icon

Friess Associates’s LeMaitre Vascular LMAT Stock Holding History

Friess Associates’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-97,598
Closed -$3.51M – 126
2019
Q4 		$3.51M Buy
+97,598
New +$3.37M 0.24% 88

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Friess Associates's LMAT Position: Q1 2020 in Review

Friess Associates sold out of LeMaitre Vascular (LMAT) in Q1 2020, closing a stake of 97,598 shares — an estimated $3.51M sold.

Friess Associates first reported a position in LMAT in Q4 2019 and held it in 1 quarter. The position peaked at $3.51M in Q4 2019. 144 funds tracked by Wall St. Rank hold LMAT as of Q1 2020.

  • Friess Associates reported no remaining LeMaitre Vascular position as of Q1 2020 after selling out during the quarter.
  • Friess Associates sold 97,598 LeMaitre Vascular shares in Q1 2020, an estimated $3.51M.
  • Friess Associates first reported a position in LeMaitre Vascular in Q4 2019 and held it in 1 quarter.
  • Friess Associates's LeMaitre Vascular position peaked at $3.51M in Q4 2019.
  • 144 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2020.

Based on Friess Associates's 13F filing for Q1 2020, filed 15 May 2020.